Provider: NIHR Journals Library Content:text/plain; charset="UTF-8" TY - JOUR LB - 1. AU - Chilcott, J AU - Lloyd-Jones, M AU - Wight, J AU - Forman, K AU - Wray, J AU - Beverley, C TI - A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus (RhD) negative J2 - Health Technol Assess PY - 2003 VL - 7 SP - 1 EP - 72 ER - TY - JOUR LB - 2. AU - Stockman, JA, III AU - de Alarcon, PA TI - Overview of the state of the art of Rh disease: history, current clinical management, and recent progress J2 - J Pediatr Hematol Oncol PY - 2001 VL - 23 SP - 385 EP - 393 ER - TY - JOUR LB - 3. AU - MacKenzie, I TI - Antenatal anti-D prophylaxis: one dose or two? J2 - Br J Midwifery PY - 2004 VL - 12 SP - 13 EP - 19 ER - TY - JOUR LB - 4. AU - Bowman, JM TI - The prevention of Rh immunization J2 - Transfusion Med Rev PY - 1988 VL - 2 SP - 129 EP - 150 ER - TY - JOUR LB - 5. AU - Filbey, D AU - Berseus, O AU - Carlberg, M TI - Occurrence of anti-D in RhD-positive mothers and the outcome of the newborns J2 - Acta Obstet Gynecol Scand PY - 1996 VL - 75 SP - 585 EP - 587 ER - TY - JOUR LB - 6. AU - Selinger, M TI - Immunoprophylaxis for rhesus disease – expensive but worth it? J2 - Br J Obstet Gynaecol PY - 1991 VL - 98 SP - 509 EP - 512 ER - TY - JOUR LB - 7. AU - Harrod, KS AU - Hanson, L AU - VandeVusse, L AU - Heywood, P TI - Rh negative status and isoimmunization update. A case-based approach to care J2 - J Perinat Neonat Nurs PY - 2003 VL - 17 SP - 166 EP - 178 ER - TY - JOUR LB - 8. AU - Tovey, LA AU - Taverner, JM TI - A case for the antenatal administration of anti-D immunoglobulin to primigravidae J2 - Lancet PY - 1981 VL - 1 SP - 878 EP - 881 ER - TY - JOUR LB - 9. AU - Urbaniak, SJ AU - Greiss, MA TI - RhD haemolytic disease of the fetus and the newborn J2 - Blood Rev PY - 2000 VL - 14 SP - 44 EP - 61 ER - TY - JOUR LB - 10. AU - Contreras, M TI - The prevention of RH haemolytic disease of the fetus and newborn – general background J2 - Br J Obstet Gynaecol PY - 1998 VL - 105 SP - 7 EP - 10 ER - TY - JOUR LB - 11. AU - Bowman, J TI - Rh-immunoglobulin: Rh prophylaxis J2 - Best Pract Res Clin Haematol PY - 2006 VL - 19 SP - 27 EP - 34 ER - TY - JOUR LB - 12. AU - Bowman, JM TI - Fetomaternal ABO incompatibility and erythroblastosis fetalis J2 - Vox Sang PY - 1986 VL - 50 SP - 104 EP - 106 ER - TY - JOUR LB - 13. AU - Tuohy, JF AU - Sangalli, M AU - Kim, L TI - Red blood cell iso-immunisation in the Wellington area of New Zealand: the case for antenatal prophylaxis J2 - Aust N Z J Obstet Gynaecol PY - 2004 VL - 44 SP - 458 EP - 459 ER - TY - JOUR LB - 14. AU - Bowman, JM AU - Friesen, AD AU - Pollock, JM AU - Taylor, WE TI - WinRho: Rh immune globulin prepared by ion exchange for intravenous use J2 - Can Med Assoc J PY - 1980 VL - 123 SP - 1121 EP - 1127 ER - TY - JOUR LB - 15. AU - Urbaniak, SJ TI - The scientific basis of antenatal prophylaxis J2 - Br J Obstet Gynaecol PY - 1998 VL - 105 SP - 11 EP - 18 ER - TY - JOUR LB - 16. AU - Stewart, G AU - Day, RE AU - Del Priore, C AU - Whittle, MJ AU - Turner, TL AU - Holland, BM TI - Developmental outcome after intravascular intrauterine transfusion for rhesus haemolytic disease J2 - Arch Dis Child Fetal Neonat Ed PY - 1994 VL - 70 SP - F52 EP - F53 ER - TY - JOUR LB - 17. AU - van Kamp, IL AU - Klumper, FJ AU - Bakkum, RSLA AU - Oepkes, D AU - Meerman, RH AU - Scherjon, SA TI - The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment J2 - Am J Obstet Gynecol PY - 2001 VL - 185 SP - 668 EP - 673 ER - TY - JOUR LB - 18. AU - Farina, A AU - Calderoni, P AU - Carinci, P AU - Rizzo, N TI - Survival analysis of transfused fetuses affected by Rh-alloimmunization J2 - Prenat Diagn PY - 2000 VL - 20 SP - 881 EP - 885 ER - TY - JOUR LB - 19. AU - Craig, S AU - Morris, K AU - Tubman, T AU - McClure, B TI - The fetal and neonatal outcomes of rhesus D antibody affected pregnancies in Northern Ireland J2 - Ir Med J PY - 2000 VL - 93 SP - 17 EP - 18 ER - TY - JOUR LB - 20. AU - Matijevic, R AU - Grgic, O AU - Klobucar, A AU - Miskovic, B TI - Diagnosis and management of Rh alloimmunization J2 - Fetal Diagn Ther PY - 2005 VL - 20 SP - 393 EP - 401 ER - TY - JOUR LB - 21. AU - Grab, D AU - Paulus, WE AU - Bommer, A AU - Buck, G AU - Terinde, R TI - Treatment of fetal erythroblastosis by intravascular transfusions: outcome at 6 years J2 - Obstet Gynecol PY - 1999 VL - 93 SP - 165 EP - 168 ER - TY - JOUR LB - 22. AU - Doyle, LW AU - Kelly, EA AU - Rickards, AL AU - Ford, GW AU - Callanan, C TI - Sensorineural outcome at 2 years for survivors of erythroblastosis treated with fetal intravascular transfusions J2 - Obstet Gynecol PY - 1993 VL - 81 SP - 931 EP - 935 ER - TY - JOUR LB - 23. AU - van Kamp, IL AU - Klumper, FJCM AU - Oepkes, D AU - Meerman, RH AU - Scherjon, SA AU - Vandenbussche, FPHA TI - Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization J2 - Am J Obstet Gynecol PY - 2005 VL - 192 SP - 171 EP - 177 ER - TY - JOUR LB - 24. AU - Harper, DC AU - Swingle, HM AU - Wiener, CP AU - Bonthius, DJ AU - Aylward, GP AU - Widness, JA TI - Long-term neurodevelopmental outcome and brain volume after treatment for hydrops fetalis by in utero intravascular transfusion J2 - Am J Obstet Gynecol PY - 2006 VL - 195 SP - 192 EP - 200 ER - TY - JOUR LB - 25. AU - Hudon, L AU - Moise, KJ, Jr AU - Hegemier, SE AU - Hill, RM AU - Moise, AA AU - Smith, EO TI - Long-term neurodevelopmental outcome after intrauterine transfusion for the treatment of fetal hemolytic disease J2 - Am J Obstet Gynecol PY - 1998 VL - 179 SP - 858 EP - 863 ER - TY - JOUR LB - 26. AU - Janssens, HM AU - de Haan, MJ AU - van Kamp, I AU - Brand, R AU - Kanhai, HH AU - Veen, S TI - Outcome for children treated with fetal intravascular transfusions because of severe blood group antagonism J2 - J Pediatr PY - 1997 VL - 131 SP - 373 EP - 380 ER - TY - JOUR LB - 27. AU - Ouwehand, WH AU - Goodyear, E AU - Camilleri-Ferrante, C AU - Burgess, C AU - Rankin, A TI - Epidemiology of RhD haemolytic disease of the newborn in East Anglia J2 - Br J Obstet Gynaecol PY - 1998 VL - 105 SP - 23 EP - 24 ER - TY - JOUR LB - 28. AU - Das, PK AU - Nair, SC AU - Harris, VK AU - Rose, D AU - Mammen, JJ AU - Bose, YN TI - Distribution of ABO and Rh-D blood groups among blood donors in a tertiary care centre in South India J2 - Trop Doct PY - 2001 VL - 31 SP - 47 EP - 48 ER - TY - JOUR LB - 29. AU - Ali, N AU - Anwar, M AU - Bhatti, FA AU - Nadeem, M AU - Nadeem, A AU - Ali, M TI - Frequency of ABO and Rh blood groups in major ethnic groups and casts of Pakistan J2 - Pakistan J Med Sci PY - 2005 VL - 21 SP - 26 EP - 29 ER - TY - JOUR LB - 30. AU - Editorial TI - Prevention of haemolytic diseases of the newborn due to anti-D J2 - Br Med J Clin Res Ed PY - 1981 VL - 282 SP - 676 EP - 677 ER - TY - JOUR LB - 31. AU - Kumar, S AU - Regan, F TI - Management of pregnancies with RhD alloimmunisation J2 - Br Med J PY - 2005 VL - 330 SP - 1255 EP - 1258 ER - TY - JOUR LB - 32. AU - Joseph, KS AU - Kramer, MS TI - The decline in Rh hemolytic disease: should Rh prophylaxis get all the credit? J2 - Am J Public Health PY - 1998 VL - 88 SP - 209 EP - 215 ER - TY - JOUR LB - 33. AU - Robson, SC AU - Lee, D AU - Urbaniak, S TI - Anti-D immunoglobulin in RhD prophylaxis J2 - Br J Obstet Gynaecol PY - 1998 VL - 105 SP - 129 EP - 134 ER - TY - JOUR LB - 34. AU - Duguid, JKM AU - Bromilow, IM TI - What is the true rate of RhD isoimmunisation in the UK? J2 - Br J Obstet Gynaecol PY - 1998 VL - 105 SP - 33 ER - TY - JOUR LB - 35. AU - Clarke, CA TI - Preventing rhesus babies: the Liverpool research and follow up J2 - Arch Dis Child PY - 1989 VL - 64 SP - 1734 EP - 1740 ER - TY - JOUR LB - 36. AU - Hussey, RM AU - Clarke, CA TI - Deaths from Rh haemolytic disease in England and Wales in 1988 and 1989 J2 - Br Med J PY - 1991 VL - 303 SP - 445 EP - 446 ER - TY - JOUR LB - 37. AU - Whitfield, CR AU - Raafat, A AU - Urbaniak, SJ TI - Underreporting of mortality from RhD haemolytic disease in Scotland and its implications: retrospective review J2 - Br Med J PY - 1997 VL - 315 SP - 1504 EP - 1505 ER - TY - JOUR LB - 38. AU - Murphy, KW AU - Whitfield, CR TI - Rhesus disease in this decade J2 - Contemp Rev Obstet Gynaecol PY - 1994 VL - 6 SP - 61 EP - 67 ER - TY - GEN LB - 39. AU - Editorial TI - Mortality statistics: childhood, infant and perinatal. Review of the Registrar General on deaths in England and Wales, 2005 CY - London PB - Office for National Statistics PY - 2007 ER - TY - JOUR LB - 40. AU - Schumacher, B AU - Moise, KJ TI - Fetal transfusion for red blood cell alloimmunization in pregnancy J2 - Obstet Gynecol PY - 1996 VL - 88 SP - 137 EP - 150 ER - TY - JOUR LB - 41. AU - Bjornson, KF AU - McLaughlin, JF TI - The measurement of health-related quality of life (HRQL) in children with cerebral palsy J2 - Eur J Neurol PY - 2001 VL - 8 SP - 183 EP - 193 ER - TY - JOUR LB - 42. AU - Livingston, MH AU - Rosendbuam, PL AU - Russell, DJ AU - Palisano, RJ TI - Quality of life among adolescents with cerebral palsy: what does the literature tell us? J2 - Dev Med Child Neurol PY - 2007 VL - 49 SP - 225 EP - 231 ER - TY - JOUR LB - 43. AU - Varni, JW AU - Burwinkle, TM AU - Sherman, SA AU - Hanna, K AU - Berrin, SJ AU - Malcarne, VL TI - Health-related quality of life in children and adolescents with cerebral palsy: hearing the voices of the children J2 - Dev Med Child Neurol PY - 2005 VL - 47 SP - 592 EP - 597 ER - TY - JOUR LB - 44. AU - Pirpiris, M AU - Gates, PE AU - McCarthy, JJ AU - D’Astous, J AU - Tylkowksi, C AU - Sanders, JO TI - Function and well-being in ambulatory children with cerebral palsy J2 - J Pediatr Orthop PY - 2006 VL - 26 SP - 119 EP - 124 ER - TY - JOUR LB - 45. AU - Dickinson, HO AU - Parkinson, KN AU - Ravens-Sieberer, U AU - Schirripa, G AU - Thyen, U AU - Arnaud, C TI - Self-reported quality of life of 8–12-year-old children with cerebral palsy: a cross-sectional European study J2 - Lancet PY - 2007 VL - 369 SP - 2171 EP - 2178 ER - TY - JOUR LB - 46. AU - Magill-Evans, J AU - Darrah, J AU - Pain, K AU - Adkins, R AU - Kratchovil, M TI - Are families with adolescents and young adults with cerebral palsy the same as other families? J2 - Dev Med Child Neurol PY - 2001 VL - 43 SP - 466 EP - 472 ER - TY - JOUR LB - 47. AU - Houlihan, CM AU - O’Donnell, M AU - Conaway, M AU - Stevenson, RD TI - Bodily pain and health-related quality of life in children with cerebral palsy J2 - Dev Med Child Neurol PY - 2004 VL - 46 SP - 305 EP - 310 ER - TY - JOUR LB - 48. AU - van der Dussen, L AU - Nieuwstraten, W AU - Roebroeck, M AU - Stam, HJ TI - Functional level of young adults with cerebral palsy J2 - Clin Rehabil PY - 2001 VL - 15 SP - 84 EP - 91 ER - TY - JOUR LB - 49. AU - Schwartz, L AU - Engel, JM AU - Jensen, MP TI - Pain in persons with cerebral palsy J2 - Arch Phys Med Rehabil PY - 1999 VL - 80 SP - 1243 EP - 1246 ER - TY - JOUR LB - 50. AU - Jahnsen, R AU - Villien, L AU - Aamodt, G AU - Stanghelle, JK AU - Holm, I TI - Musculoskeletal pain in adults with cerebral palsy compared with the general population J2 - J Rehabil Med PY - 2004 VL - 36 SP - 78 EP - 84 ER - TY - JOUR LB - 51. AU - Bottos, M AU - Feliciangeli, A AU - Sciuto, L AU - Gericke, C AU - Vianello, A TI - Functional status of adults with cerebral palsy and implications for treatment of children J2 - Dev Med Child Neurol PY - 2001 VL - 43 SP - 516 EP - 528 ER - TY - JOUR LB - 52. AU - Murphy, KP AU - Molnar, GE AU - Lankasky, K TI - Employment and social issues in adults with cerebral palsy J2 - Arch Phys Med Rehabil PY - 2000 VL - 81 SP - 807 EP - 811 ER - TY - JOUR LB - 53. AU - Margolis, AC TI - Implications of prelingual deafness J2 - Lancet PY - 2001 VL - 358 SP - 76 ER - TY - JOUR LB - 54. AU - Wake, M AU - Hughes, EK AU - Collins, CM AU - Poulakis, Z TI - Parent-reported health-related quality of life in children with congenital hearing loss: a population study J2 - Ambul Pediatr PY - 2004 VL - 4 SP - 411 EP - 417 ER - TY - JOUR LB - 55. AU - Van Oyen, H AU - Tafforeau, J AU - Demarest, S TI - The impact of hearing disability on well-being and health J2 - Sozial- und Praventivmedizin PY - 2001 VL - 46 SP - 335 EP - 343 ER - TY - JOUR LB - 56. AU - Jacob, SR AU - Scandrett-Hibdon, S TI - Mothers grieving the death of a child. Case reports of maternal grief J2 - Nurse Pract PY - 1994 VL - 19 SP - 60 EP - 65 ER - TY - JOUR LB - 57. AU - Badenhorst, W AU - Hughes, P TI - Psychological aspects of perinatal loss J2 - Best Pract Res Clin Obstet Gynaecol PY - 2007 VL - 21 SP - 249 EP - 259 ER - TY - JOUR LB - 58. AU - Hutti, MH TI - Social and professional support needs of families after perinatal loss J2 - J Obstet Gynecol Neonat Nurs PY - 2004 VL - 34 SP - 630 EP - 638 ER - TY - JOUR LB - 59. AU - Callister, LC TI - Perinatal loss. A family perspective J2 - J Perinat Neonat Nurs PY - 2006 VL - 20 SP - 227 EP - 234 ER - TY - JOUR LB - 60. AU - Vance, JC AU - Foster, WJ AU - Najman, JM AU - Embelton, G AU - Thearle, MJ AU - Hodgen, FM TI - Early parental responses to sudden infant death, stillbirth or neonatal death J2 - Med J Aust PY - 1991 VL - 155 SP - 292 EP - 297 ER - TY - JOUR LB - 61. AU - Vance, JC AU - Najman, JM AU - Thearle, MJ AU - Embelton, G AU - Foster, WJ AU - Boyle, FM TI - Psychological changes in parents eight months after the loss of an infant from stillbirth, neonatal death, or sudden infant death syndrome – a longitudinal study J2 - Pediatrics PY - 1995 VL - 96 SP - 998 ER - TY - JOUR LB - 62. AU - Janssen, HJEM AU - Cuisinier, MCJ AU - de Graauw, KPHM AU - Hoogduin, KAL TI - A prospective study of risk factors predicting grief intensity following pregnancy loss J2 - Arch Gen Psychiatry PY - 1997 VL - 54 SP - 56 EP - 61 ER - TY - JOUR LB - 63. AU - Zeanah, CH AU - Dailey, JV AU - Rosenblatt, MJ AU - Saller, DN TI - Do women grieve after terminating pregnancies because of fetal anomalies? A controlled investigation J2 - Obstet Gynecol PY - 1993 VL - 82 SP - 270 EP - 275 ER - TY - JOUR LB - 64. AU - Kolker, A AU - Burke, BM TI - Grieving the wanted child: ramifications of abortion after prenatal diagnosis of abnormality J2 - Health Care Women Int PY - 1993 VL - 14 SP - 513 EP - 526 ER - TY - CHAP LB - 65. AU - Roman, A AU - Pernell, M TI - Late pregnancy complications A2 - Decherney, AH A2 - Nathan, L T2 - Current obstetric and gynecologic diagnosis and treatment ET - 9th CY - New York PB - McGraw-Hill Professional PY - 2002 SP - 296 EP - 300 ER - TY - JOUR LB - 66. AU - Brewaeys, A TI - Review: parent–child relationships and child development in donor insemination families J2 - Hum Reprod Update PY - 2001 VL - 7 SP - 38 EP - 46 ER - TY - JOUR LB - 67. AU - Durna, EM AU - Bebe, J AU - Leader, LR AU - Steigrad, SJ AU - Garrett, DG TI - Donor insemination: effects on parents J2 - Med J Aust PY - 1995 VL - 163 SP - 248 EP - 251 ER - TY - JOUR LB - 68. AU - Baron, L AU - Blanco, L AU - Valzacchi, GR AU - Pasqualini, S TI - Oocyte donation (OD) and donor insemination (DI): a comparative psychological study of parents and children J2 - Fertil Steril PY - 1998 VL - 70 SP - 278S ER - TY - JOUR LB - 69. AU - Bode, H AU - Weidner, K AU - Storck, M TI - Quality of life in families of children with disabilities J2 - Dev Med Child Neurol PY - 2000 VL - 42 SP - 354 ER - TY - JOUR LB - 70. AU - Wake, M AU - Salmon, L AU - Reddihough, D TI - Health status of Australian children with mild to severe cerebral palsy: cross-sectional survey using the Child Health Questionnaire J2 - Dev Med Child Neurol PY - 2003 VL - 45 SP - 194 EP - 199 ER - TY - JOUR LB - 71. AU - Vargus-Adams, J TI - Health-related quality of life in childhood cerebral palsy J2 - Arch Phys Med Rehabil PY - 2005 VL - 86 SP - 940 EP - 945 ER - TY - JOUR LB - 72. AU - Brehaut, JC AU - Kohen, DE AU - Raina, P AU - Walter, SD AU - Russell, DJ AU - Swinton, M TI - The health of primary caregivers of children with cerebral palsy: how does it compare with that of other Canadian caregivers? J2 - Pediatrics PY - 2004 VL - 114 SP - e182 EP - e191 ER - TY - JOUR LB - 73. AU - Eker, L AU - Tuzun, EH TI - An evaluation of quality of life of mothers of children with cerebral palsy J2 - Disabil Rehabil PY - 2004 VL - 26 SP - 1354 EP - 1359 ER - TY - JOUR LB - 74. AU - McConnell, D AU - Llewellyn, G TI - Health of mothers of school-age children with disabilities J2 - Aust N Z J Public Health PY - 2006 VL - 30 SP - 572 EP - 574 ER - TY - JOUR LB - 75. AU - Emerson, E TI - Mothers of children and adolescents with intellectual disability: social and economic situation, mental health status, and the self-assessed social and psychological impact of the child’s difficulties J2 - J Intellect Disabil Res PY - 2003 VL - 47 SP - 385 EP - 399 ER - TY - JOUR LB - 76. AU - Emerson, E AU - Hatton, C AU - Llewellyn, G AU - Blacker, J AU - Graham, H TI - Socio-economic position, household composition, health status and indicators of the well-being of mothers of children with and without intellectual disabilities J2 - J Intellect Disabil Res PY - 2006 VL - 50 SP - 862 EP - 873 ER - TY - JOUR LB - 77. AU - Parish, SL AU - Seltzer, MM AU - Greenberg, JS AU - Floyd, F TI - Economic implications of caregiving at midlife: comparing parents with and without children who have developmental disabilities J2 - Ment Retard PY - 2004 VL - 42 SP - 413 EP - 426 ER - TY - JOUR LB - 78. AU - Bat-Chava, Y AU - Martin, D TI - Sibling relationships of deaf children: the impact of child and family characteristics J2 - Rehabil Psychol PY - 2002 VL - 47 SP - 73 EP - 91 ER - TY - JOUR LB - 79. AU - Oepkes, D AU - van Scheltema, PA TI - Intrauterine fetal transfusions in the management of fetal anemia and fetal thrombocytopenia J2 - Semin Fetal Neonat Med PY - 2007 VL - 12 SP - 432 EP - 438 ER - TY - ELEC LB - 80. AU - British Committee for Standards in Haematology TI - Guideline for blood grouping and antibody testing in pregnancy PY - 2006 UR - www.bcshguidelines.com/pdf/pregnancy_070606.pdf ER - TY - JOUR LB - 81. AU - Ulm, B AU - Svolba, G AU - Ulm, MR AU - Bernaschek, G AU - Panzer, S TI - Male fetuses are particularly affected by maternal alloimmunization to D J2 - Transfusion PY - 1999 VL - 39 SP - 169 EP - 173 ER - TY - JOUR LB - 82. AU - Murray, NA AU - Roberts, IAG TI - Haemolytic disease of the newborn J2 - Arch Dis Child Fetal Neonat J2 - Ed PY - 2007 VL - 92 SP - F83 EP - F88 ER - TY - JOUR LB - 83. AU - Howard, H AU - Martlew, V AU - McFadyen, I AU - Clarke, C AU - Duguid, J AU - Bromilow, I TI - Consequences for fetus and neonate of maternal red cell allo-immunisation J2 - Arch Dis Child Fetal Neonat Ed PY - 1998 VL - 78 SP - F62 EP - F66 ER - TY - JOUR LB - 84. AU - Walkinshaw, S TI - Antenatal prophylaxis – proposing J2 - Br J Obstet Gynaecol PY - 1998 VL - 105 SP - 25 ER - TY - JOUR LB - 85. AU - Mohr, PE AU - Feldman, JJ AU - Dunbar, JL AU - McConkey-Robbins, A AU - Niparko, JK AU - Rittenhouse, RK TI - The societal costs of severe to profound hearing loss in the United States J2 - Int J Technol Assess Health Care PY - 2000 VL - 16 SP - 1120 EP - 1135 ER - TY - JOUR LB - 86. AU - Schroeder, L AU - Petrou, S AU - Kennedy, C AU - McCann, D AU - Law, C AU - Watkin, PM TI - The economic costs of congenital bilateral permanent childhood hearing impairment J2 - Pediatrics PY - 2006 VL - 117 SP - 1101 EP - 1112 ER - TY - GEN LB - 87. AU - National Institute for Clinical Excellence TI - Guidance on the use of routine antenatal anti-D prophylaxis for RhD-negative women CY - London PB - NICE PY - 2002 ER - TY - JOUR LB - 88. AU - Lee, D AU - Contreras, M AU - Entwistle, CC AU - Forman, KM AU - Fraser, ID AU - Gascoigne, EW TI - Recommendations for the use of anti-D immunoglobulin J2 - Prescribers’ J PY - 1991 VL - 31 SP - 145 ER - TY - GEN LB - 89. AU - Royal College of Physicians and Royal College of Pathologists TI - National Institute for Health and Clinical Excellence review of technology appraisal guidance – No. 41: guidance on the use of routine antenatal anti-D prophylaxis for RhD-negative women CY - London PB - NICE PY - 2007 ER - TY - GEN LB - 90. AU - Nottingham City Primary Care Trust TI - Health technology appraisal: pregnancy – routine anti-D prophylaxis for rhesus negative women (review of TA41) PY - 2007 ER - TY - BOOK LB - 91. AU - Dash, CH TI - Submission to NICE on the use of anti-D as routine antenatal prophylaxis (RANP) to aid updating technology appraisal guidance CY - Elstree PB - Bio Products Laboratory (BPL) PY - 2007 ER - TY - GEN LB - 92. AU - CSL Behring UK TI - Rhophylac®manufacturer’s submission. Routine antenatal anti-D prophylaxis for Rh D-negative women PY - 2007 ER - TY - GEN LB - 93. AU - CSL Behring UK TI - Initial comments on the technical content of the assessment report PY - 2008 ER - TY - GEN LB - 94. AU - British Committee for Standards in Haematology TI - Guidelines for the use of prophylactic anti-D immunoglobulin CY - London PB - BCSH PY - 2006 ER - TY - JOUR LB - 95. AU - Finning, KM TI - Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service J2 - Transfusion PY - 2002 VL - 42 SP - 1079 EP - 1085 ER - TY - JOUR LB - 96. AU - Daniels, G AU - Finning, K AU - Martin, P AU - Soothill, P TI - Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn J2 - Vox Sang PY - 2004 VL - 87 SP - 225 EP - 232 ER - TY - JOUR LB - 97. AU - ACOG practice bulletin TI - Prevention of Rh D alloimmunization. Number 4, May 1999 (replaces educational bulletin Number 147, October 1990). Clinical management guidelines for obstetrician-gynecologists. American College of Obstetrics and Gynecology J2 - Int J Gynecol Obstet PY - 1999 VL - 66 SP - 63 EP - 70 ER - TY - JOUR LB - 98. AU - Smith, JA TI - Issues in anti-D plasma procurement J2 - Br J Obstet Gynaecol PY - 1998 VL - 105 SP - 32 ER - TY - JOUR LB - 99. AU - Schiff, P AU - Kelle, AJ AU - Wylie, B TI - Meeting the demand for anti-D in Australia J2 - Br J Obstet Gynaecol PY - 1998 VL - 105 SP - 32 ER - TY - JOUR LB - 100. AU - MacKenzie, IZ AU - Bichler, J AU - Mason, GC AU - Lunan, CB AU - Stewart, P AU - Al-Azzawi, F TI - Efficacy and safety of a new, chromatographically purified rhesus (D) immunoglobulin J2 - Eur J Obstet Gynecol Reprod Biol PY - 2004 VL - 117 SP - 154 EP - 161 ER - TY - JOUR LB - 101. AU - Bowman, JM TI - The advantages of intravenous Rh-immune globulin J2 - Clin Obstet Gynecol PY - 1982 VL - 25 SP - 341 EP - 347 ER - TY - GEN LB - 102. AU - Baxter Healthcare TI - The clinical and cost-effectiveness of anti-D prophylaxis for rhesus negative women in pregnancy CY - Compton, Berkshire PB - Baxter Healthcare Ltd PY - 2007 ER - TY - GEN LB - 103. AU - Harrop, S TI - Letter from Baxter Healthcare to NICE PY - 2007 ER - TY - ELEC LB - 104. AU - Wickham, S TI - Routine antenatal anti-D – a review of the evidence PY - 2001 UR - www.bcshguidelines.com/pdf/pregnancy_070606.pdf ER - TY - JOUR LB - 105. AU - Maayan-Metzger, A AU - Schwartz, T AU - Sulkes, J AU - Merlob, P TI - Maternal anti-D prophylaxis during pregnancy does not cause neonatal haemolysis J2 - Arch Dis Child Fetal Neonat Ed PY - 2001 VL - 84 SP - F60 EP - F62 ER - TY - JOUR LB - 106. AU - Tabor, E TI - The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1 J2 - Transfusion PY - 1999 VL - 39 SP - 1160 EP - 1168 ER - TY - JOUR LB - 107. AU - Foster, PR AU - McIntosh, RV AU - Welch, AG TI - Hepatitis C infection from anti-D immunoglobulin J2 - Lancet PY - 1995 VL - 346 SP - 372 ER - TY - JOUR LB - 108. AU - Meisel, H AU - Reip, A AU - Faltus, B AU - Lu, M AU - Porst, H AU - Wiese, M TI - Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin J2 - Lancet PY - 1995 VL - 345 SP - 1209 EP - 1211 ER - TY - JOUR LB - 109. AU - Power, JP AU - Lawlor, E AU - Davidson, F AU - Yap, PL AU - Kenny-Walsh, E AU - Whelton, MJ TI - Hepatitis C viraemia in recipients of Irish intravenous anti-D immunoglobulin J2 - Lancet PY - 1994 VL - 344 SP - 1166 EP - 1167 ER - TY - JOUR LB - 110. AU - Smith, DB AU - Lawlor, E AU - Power, J AU - O’Riordan, J AU - McAllister, J AU - Lycett, C TI - A second outbreak of hepatitis C virus infection from anti-D immunoglobulin in Ireland J2 - Vox Sang PY - 1999 VL - 76 SP - 175 EP - 180 ER - TY - ELEC LB - 111. AU - CSL Behring UK TI - Rhophylac 300 (1500 IU) PY - 2006 UR - http://emc.medicines.org.uk/emc/assets/c/html/DisplayDoc.asp?DocumentID=12087 ER - TY - JOUR LB - 112. AU - Turner, ML AU - Ironside, JW TI - New-variant Creutzfeldt-Jakob disease: the risk of transmission by blood transfusion J2 - Blood Rev PY - 1998 VL - 12 SP - 255 EP - 268 ER - TY - JOUR LB - 113. AU - Editorial team TI - Fourth case of transfusion-associated vCJD infection in the United Kingdom J2 - Eurosurveillance PY - 2007 VL - 12 IS - 3 ER - TY - JOUR LB - 114. AU - Burnouf, T AU - Padilla, A TI - Current strategies to prevent transmission of prions by human plasma derivatives J2 - Transfusion Clin Biol PY - 2006 VL - 13 SP - 320 EP - 328 ER - TY - ELEC LB - 115. AU - BPL (Bio Products Laboratory) TI - D-GAM(R), human anti-D immunoglobulin PY - 2004 UR - www.sahha.gov.mt/showdoc.aspx?id=771%26filesource=4%26file=dh50_07_Anti-d_spc.pdf ER - TY - GEN LB - 116. AU - British Medical Association and Royal Pharmaceutical Society of Great Britain TI - British national formulary (BNF) CY - London CY - BMA and RPS PY - 2007 ER - TY - ELEC LB - 117. AU - Baxter Healthcare Ltd TI - Summary of product characteristics PY - 2003 UR - www.ecomm.baxter.com/ecatalog/loadResource.do?bid=13716 ER - TY - ELEC LB - 118. TI - WinRho(R) SDF product monograph PY - 2007 UR - www.cangene.com/pdf/2006/Healthcare%20info%20for%20website%20070109.pdf ER - TY - ELEC LB - 119. AU - Baxter Healthcare Corporation TI - Rho(D) immune globulin intravenous (human). WinRho(R) SDF PY - 2005 UR - www.fda.gov/medwatch/SAFETY/2006/WinRho_PI_%2021-DEC-2005.pdf ER - TY - JOUR LB - 120. AU - Fung Kee Fung, K AU - Eason, E AU - Crane, J AU - Armson, A AU - De La Ronde, S AU - Farine, D TI - Maternal–Fetal Medicine Committee, Genetics Committee. Prevention of Rh alloimmunization J2 - J Obstet Gynaecol Canada PY - 2003 VL - 25 SP - 765 EP - 773 ER - TY - JOUR LB - 121. AU - Chaffe, B AU - Ford, J AU - Bills, V TI - Routine antenatal anti-D prophylaxis and patient compliance with the two-dose regimen J2 - Transfusion Med PY - 2007 VL - 17 SP - 399 EP - 403 ER - TY - JOUR LB - 122. AU - MacKenzie, IZ AU - Findlay, J AU - Thompson, K AU - Roseman, F TI - Compliance with routine antenatal rhesus D prophylaxis and the impact on sensitisations: observations over 14 years J2 - Int J Obstet Gynaecol PY - 2006 VL - 113 SP - 839 EP - 843 ER - TY - GEN LB - 123. AU - Royal College of Nursing National Institute for Health and Clinical Excellence TI - Health technology appraisal: pregnancy – routine anti-D prophylaxis for rhesus negative women (review of TA41) PY - 2007 ER - TY - GEN LB - 124. AU - NHS Centre for Reviews and Dissemination TI - Undertaking systematic reviews of research on effectiveness: CRD’s guidance for those carrying out or commissioning reviews ET - 2nd CY - York PB - NHS Centre for Reviews and Dissemination PY - 2001 ER - TY - JOUR LB - 125. AU - Huchet, J AU - Dallemagne, S AU - Huchet, C AU - Brossard, Y AU - Larsen, M AU - Parnet-Mathieu, F TI - Application anté-partum du traitement préventif d’immunisation rhésus D chez les femmes rhésus négatif. Evaluation parallèle des passages transplacentaires d’hématies foetales. Résultats d’une étude multicentrique menée en région parisienne [Ante-partum administration of preventive treatment of Rh-D immunization in rhesus-negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region] J2 - Journal de Gynecologie, Obstetrique et Biologie de la Reproduction PY - 1987 VL - 16 SP - 101 EP - 111 ER - TY - JOUR LB - 126. AU - MacKenzie, IZ AU - Bowell, P AU - Gregory, H AU - Pratt, G AU - Guest, C AU - Entwistle, CC TI - Routine antenatal Rhesus D immunoglobulin prophylaxis: the results of a prospective 10 year study J2 - Br J Obstet Gynaecol PY - 1999 VL - 106 SP - 492 EP - 497 ER - TY - JOUR LB - 127. AU - Mayne, S AU - Parker, JH AU - Harden, TA AU - Dodds, SD AU - Beale, JA TI - Rate of RhD sensitisation before and after implementation of a community based antenatal prophylaxis programme J2 - Br Med J PY - 1997 VL - 315 SP - 1588 ER - TY - JOUR LB - 128. AU - Tovey, LA AU - Townley, A AU - Stevenson, BJ AU - Taverner, J TI - The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae J2 - Lancet PY - 1983 VL - 2 SP - 244 EP - 246 ER - TY - JOUR LB - 129. AU - Bowman, JM AU - Chown, B AU - Lewis, M AU - Pollock, JM TI - Rh isoimmunization during pregnancy: antenatal prophylaxis J2 - Can Med Assoc J PY - 1978 VL - 118 SP - 623 EP - 627 ER - TY - JOUR LB - 130. AU - Bowman, JM AU - Pollock, JM TI - Antenatal prophylaxis of Rh isoimmunization: 28-weeks’-gestation service program J2 - Can Med Assoc J PY - 1978 VL - 118 SP - 627 EP - 630 ER - TY - JOUR LB - 131. AU - Bowman, JM AU - Pollock, JM TI - Failures of intravenous Rh immune globulin prophylaxis: an analysis of the reasons for such failures J2 - Transfusion Med Rev PY - 1987 VL - 1 SP - 101 EP - 112 ER - TY - JOUR LB - 132. AU - Trolle, B TI - Prenatal Rh-immune prophylaxis with 300 micrograms immune globulin anti-D in the 28th week of pregnancy J2 - Acta Obstet Gynecol Scand PY - 1989 VL - 68 SP - 45 EP - 47 ER - TY - JOUR LB - 133. AU - Thornton, JG AU - Page, C AU - Foote, G AU - Arthur, GR AU - Tovey, LA AU - Scott, JS TI - Efficacy and long term effects of antenatal prophylaxis with anti-D immunoglobulin J2 - Br Med J PY - 1989 VL - 298 SP - 1671 EP - 1673 ER - TY - JOUR LB - 134. AU - Hermann, M AU - Kjellman, H AU - Ljunggren, C TI - Antenatal prophylaxis of Rh immunization with 250 mcg anti-D immunoglobulin J2 - Acta Obstet Gynecol Scand PY - 1984 VL - 63 IS - Suppl 124 SP - 4 EP - 14 ER - TY - JOUR LB - 135. AU - Lee, D AU - Rawlinson, VI TI - Multicentre trial of antepartum low-dose anti-D immunoglobulin J2 - Transfusion Med PY - 1995 VL - 5 SP - 15 EP - 19 ER - TY - JOUR LB - 136. AU - Parsons, ML AU - Van den Hoj, MC AU - Armson, BA AU - Coffey, J AU - Liston, RM AU - Peddle, LJ TI - A comparison of the rate of RhD alloimmunisation between Nova Scotia and Scotland J2 - Br J Obstet Gynaecol PY - 1998 VL - 105 SP - 39 ER - TY - JOUR LB - 137. AU - MacKenzie, IZ AU - Bowell, PJ AU - Pratt, G AU - Gregory, H AU - Guest, C AU - Entwistle, CC TI - Routine antenatal anti-D prophylaxis: results of a prospective 10-year study J2 - Br J Obstet Gynaecol PY - 1998 VL - 105 SP - 25 ER - TY - JOUR LB - 138. AU - Eklund, J AU - Nevanlinna, HR TI - Prevention of Rh immunization in Finland. Results obtained in a two-year national anti-D programme J2 - Duodecim PY - 1971 VL - 87 SP - 861 EP - 866 ER - TY - JOUR LB - 139. AU - Potron, G AU - Quereux, C AU - Freal, C TI - Prevention of Rh disease by anti-D plasma. A 2-year study J2 - Revue Francaise de Transfusion PY - 1973 VL - 16 SP - 11 EP - 31 ER - TY - BOOK LB - 140. AU - Weaver, J TI - A multicentre study to examine the potential effect of monolocal anti-D IgG on prevention of haemolytic disease of the new-born when given routinely to RhD negative pregnant women both antenatally and at delivery PY - 2000 PB - National Research Register UR - www.nrr.nhs.uk/ ER - TY - JOUR LB - 141. AU - Koelewijn, JM TI - Effect of a single gift of antenatal anti-D-prophylaxis with 1000 IU in week 30 on the incidence of rhesus-D-immunization in the first trimester of next pregnancy J2 - Vox Sang PY - 2003 VL - 91 SP - 17 ER - TY - JOUR LB - 142. AU - Davey, MG AU - Zipursky, A TI - McMaster Conference on prevention of Rh immunization J2 - Vox Sang PY - 1979 VL - 36 SP - 50 EP - 64 ER - TY - JOUR LB - 143. AU - Urbaniak, J AU - Greiss, A AU - Promwong, C AU - Witterick, R AU - Burnett, J TI - Alloimmunisation in D negative women following routine antenatal anti-D immunoglobulin prophylaxis (RAADP) in the north east of Scotland: a five-year retrospective study J2 - Vox Sang PY - 2006 VL - 91 SP - 136 EP - 137 ER - TY - JOUR LB - 144. AU - MacKenzie, IZ AU - Roseman, F AU - Findlay, J AU - Thompson, K AU - McPherson, K TI - Clinical validation of routine antenatal anti-D prophylaxis questions the modelling predictions adopted by NICE for rhesus D sensitisation rates: results of a longitudinal study J2 - Eur J Obstet Gynecol Reprod Biol PY - 2007 VL - 139 IS - 1 SP - 38 EP - 42 ER - TY - ELEC LB - 145. AU - Committee for Proprietary Medicinal Products (CPMP) TI - Note for guidance on the clinical investigation of human anti-D immunoglobulin for intravenous and/or intramuscular use PY - 2000 UR - www.emea.europa.eu/pdfs/human/bpwg/057599en.pdf ER - TY - JOUR LB - 146. AU - McSweeney, E AU - Kirkham, J AU - Vinall, P AU - Flanagan, P TI - An audit of anti-D sensitisation in Yorkshire J2 - Br J Obstet Gynaecol PY - 1998 VL - 105 SP - 1091 EP - 1094 ER - TY - JOUR LB - 147. AU - Ghosh, S AU - Murphy, WG TI - Implementation of the rhesus prevention programme: a prospective study J2 - Scott Med J PY - 1994 VL - 39 SP - 147 EP - 149 ER - TY - JOUR LB - 148. AU - Gilling-Smith, C AU - Toozs-Hobson, P AU - Potts, DJ AU - Touquet, R AU - Beard, RW TI - Management of bleeding in early pregnancy in accident and emergency departments J2 - Br Med J PY - 1994 VL - 309 SP - 574 EP - 575 ER - TY - JOUR LB - 149. AU - Howard, H AU - Martlew, VJ AU - McFadyen, IR AU - Clarke, CA TI - Preventing Rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed? J2 - J Obstet Gynaecol PY - 1997 VL - 104 SP - 37 EP - 41 ER - TY - JOUR LB - 150. AU - Vause, S AU - Maresh, M TI - Indicators of quality of antenatal care: a pilot study J2 - Br J Obstet Gynaecol PY - 1999 VL - 106 SP - 197 EP - 205 ER - TY - JOUR LB - 151. AU - Vause, S AU - Wray, J AU - Bailie, C TI - Management of women who are Rhesus D negative in Northern Ireland J2 - J Obstet Gynaecol PY - 2000 VL - 20 SP - 374 EP - 377 ER - TY - ELEC LB - 152. AU - Turner, RM AU - Spiegelhalter, DJ AU - Smith, GCS AU - Thompson, SG TI - Bias modelling in evidence synthesis PY - 2007 UR - www.mrc-bsu.cam.ac.uk/BSUsite/Publications/Preprints/biasmodelling.pdf ER - TY - JOUR LB - 153. AU - Tovey, GH TI - Should anti-D immunoglobulin be given antenatally? J2 - Lancet PY - 1980 VL - 2 SP - 466 EP - 468 ER - TY - JOUR LB - 154. AU - Crowther, CA AU - Middleton, P TI - Anti-D administration in pregnancy for preventing Rhesus alloimmunisation J2 - Cochrane Database Syst Rev PY - 1999 VL - 1 ER - TY - RPRT LB - 155. AU - Chilcott, J AU - Lloyd Jones, M AU - Wight, J AU - Forman, K AU - Wray, J AU - Beverley, C TI - Assessment report of the clinical effectiveness and cost effectiveness of routine anti-D prophylaxis for pregnant women who are RhD-negative PB - NICE PY - 2002 UR - www.nice.org.uk/guidance/index.jsp?action=download%26o=32364 ER - TY - JOUR LB - 156. AU - Adams, MM AU - Marks, JS AU - Koplan, JP TI - Cost implications of routine antenatal administration of Rh immune globulin J2 - Am J Obstet Gynecol PY - 1984 VL - 149 SP - 633 EP - 638 ER - TY - JOUR LB - 157. AU - Baskett, TF AU - Parsons, ML TI - Prevention of Rh(D) alloimmunization: a cost-benefit analysis J2 - Can Med Assoc J PY - 1990 VL - 142 SP - 337 EP - 339 ER - TY - JOUR LB - 158. AU - Lim, OW AU - Fleisher, AA AU - Ziel, HK TI - Reduction of Rh0(D) sensitization: a cost-effective analysis J2 - Obstet Gynecol PY - 1982 VL - 59 SP - 477 EP - 480 ER - TY - BOOK LB - 159. AU - Selinger, M TI - The pharmacoeconomics of antenatal prophylaxis TI - Building on success: antenatal prophylaxis CY - London PB - Bio Products Laboratory PY - 1997 SP - 6 EP - 7 ER - TY - JOUR LB - 160. AU - Torrance, GW AU - Zipursky, A TI - Cost-effectiveness of antepartum prevention of Rh immunization J2 - Clin Perinatol PY - 1984 VL - 11 SP - 267 EP - 281 ER - TY - BOOK LB - 161. AU - Vick, S AU - Cairns, J AU - Urbaniak, S AU - Whitfield, C AU - Rafaat, A TI - An economic evaluation of antenatal anti-D prophylaxis in Scotland CY - Aberdeen PB - Aberdeen University, Health Economics Research Unit PY - 1995 ER - TY - JOUR LB - 162. AU - Vick, S AU - Cairns, J AU - Urbaniak, S AU - Whitfield, C AU - Raafat, A TI - Cost-effectiveness of antenatal anti-D prophylaxis J2 - Health Econ PY - 1996 VL - 5 SP - 319 EP - 328 ER - TY - JOUR LB - 163. AU - Tovey, LAD TI - Antenatal anti-D immunoglobulin J2 - Lancet PY - 1983 VL - 2 SP - 918 ER - TY - JOUR LB - 164. AU - Chilcott, J AU - Tappenden, P AU - Lloyd Jones, M AU - Wight, J AU - Forman, K AU - Wray, J TI - The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative J2 - Int J Obstet Gynaecol PY - 2004 VL - 111 SP - 903 EP - 907 ER - TY - GEN LB - 165. AU - Office for National Statistics TI - Birth statistics. Review of the Registrar General on births and patterns of family building in England and Wales 2005 CY - London PB - Stationery Office PY - 2007 ER - TY - JOUR LB - 166. AU - Saigal, S AU - Stoskopf, B AU - Pinelli, J AU - Streiner, D AU - Hoult, L AU - Paneth, N TI - Self-perceived health-related quality of life of former extremely low birth weight infants at young adulthood J2 - Pediatrics PY - 2006 VL - 118 SP - 1140 EP - 1148 ER - TY - BOOK LB - 167. AU - Curtis, L AU - Netten, A TI - Unit costs of health and social care CY - Canterbury PB - PPSRU, University of Kent PY - 2006 ER - TY - ELEC LB - 168. AU - Department of Health TI - HC12: Charges and optical voucher values PY - 2007 UR - www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4131675 ER - TY - JOUR LB - 169. AU - Rosenbaum, PL AU - Livingston, MH AU - Palisano, RJ AU - Galuppi, BE AU - Russell, DJ TI - Quality of life and health-related quality of life of adolescents with cerebral palsy J2 - Dev Med Child Neurol PY - 2007 VL - 49 SP - 516 EP - 521 ER - TY - JOUR LB - 170. AU - Beecham, J AU - O’Neill, T AU - Goodman, R TI - Supporting young adults with hemiplegia: services and costs J2 - Health Soc Care Community PY - 2001 VL - 9 SP - 51 EP - 59 ER - TY - JOUR LB - 171. AU - Hemming, K AU - Hutton, J AU - Colver, A AU - Platt, MJ TI - Regional variation in survival of people with cerebral palsy in the United Kingdom J2 - Pediatrics PY - 2005 VL - 116 SP - 1383 ER - TY - JOUR LB - 172. AU - Greenough, A AU - Hartnoll, G AU - Hambley, H AU - Richards, J TI - Treatment requirement of infants with rhesus isoimmunisation within a geographically defined area J2 - Arch Dis Child Fetal Neonat Ed PY - 2002 VL - 87 SP - F202 EP - F203 ER - TY - ELEC LB - 173. AU - Department of Health TI - NHS reference costs 2005–06 UR - www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_062884 PY - 2006 ER - TY - ELEC LB - 174. AU - Oswald, A AU - Powdthavee, N TI - Death and the calculation of hedonic damages PY - 2007 UR - www.shef.ac.uk/content/1/c6/07/54/59/oswald.pdf ER - TY - BOOK LB - 175. AU - Ospienko, L TI - RhD NIPD in the UK CY - Kenilworth, UK PB - Safe Network PY - 2007 ER - TY - JOUR LB - 176. AU - Bichler, J AU - Schondorfer, G AU - Pabst, G AU - Andresen, I TI - Pharmacokinetics of anti-D IgG in pregnant RhD-negative women J2 - Int J Obstet Gynaecol PY - 2003 VL - 110 SP - 39 EP - 45 ER - TY - JOUR LB - 177. AU - Kennedy, MS AU - McNanie, J AU - Waheed, A TI - Detection of anti-D following antepartum injections of Rh immune globulin J2 - Immunohematology PY - 1998 VL - 14 SP - 138 EP - 140 ER - TY - JOUR LB - 178. AU - Witter, FR AU - Shirey, RS AU - Nicol, SL AU - Ness, PM TI - Postinjection kinetics of antepartum Rh immune globulin J2 - Am J Obstet Gynecol PY - 1990 VL - 163 SP - 786 ER -